Trial Profile

Treatment of Chronic Idiopathic Cough (CIC) and Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF) with PA101

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 25 Sep 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sodium cromoglicate (Primary)
Indications Cough
Focus Proof of concept; Therapeutic Use
Sponsors Patara Pharma

Most Recent Events

21 Sep 2017 According to a Patara Pharma media release, data were published in The Lancet Respiratory Medicine.
24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
07 Sep 2016 Primary endpoint has been met. (cough frequency), as reported by a Patara Pharma media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com